Dk. Moscatello et al., DECORIN SUPPRESSES TUMOR-CELL GROWTH BY ACTIVATING THE EPIDERMAL GROWTH-FACTOR RECEPTOR, The Journal of clinical investigation, 101(2), 1998, pp. 406-412
Decorin, a small leucine-rich proteoglycan, is capable of suppressing
the growth of various tumor cell lines when expressed ectopically. In
this report, we investigated the biochemical mechanism by which decori
n inhibits cell cycle progression. In A431 squamous carcinoma cells, d
ecorin proteoglycan or protein core induced a marked growth suppressio
n, when either exogenously added or endogenously produced by a transge
ne. Decorin caused rapid phosphorylation of the EGF receptor and a con
current activation of mitogen-activated protein (MAP) kinase signal pa
thway. This led to a protracted induction of endogenous p21, a potent
inhibitor of cyclin-dependent kinases, and ultimate cell cycle arrest.
Biglycan, a related proteoglycan, had no effect. Moreover, decorin ac
tivated the EGF receptor/MAP kinase/p21 axis in cell lines of various
histogenetic backgrounds. These results provide the first evidence tha
t EGF and decorin converge functionally to regulate the cell cycle thr
ough activation of a common pathway which ultimately leads to growth s
uppression.